Partnership to improve heart disease therapy
BIOTRONIK, a global producer of cardio- and endovascular medical products, has announced a strategic partnership with GenesisCare, the largest group of private practice cardiologists in Australia, to enhance outcomes for Australian cardiac patients.
Over the course of three years the partners will initiate interdisciplinary research projects focusing on better data sharing, care pathways and integration, as well as tracking outcomes. BIOTRONIK will contribute its vast technological knowledge to the partnership, while GenesisCare has established systems to monitor and measure patient outcomes.
“With the necessary technology and know-how, we aim to improve patient outcomes with more responsive, personalised and appropriate care,” said Dr Stephen Worthley, Executive Manager at GenesisCare. “This could lead to fewer adverse events, earlier detection of preventable problems and reduced need for hospitalisation.”
Cardiac patients can benefit from this new approach in terms of fewer hospital visits and complications, and lower mortality. This will ultimately translate into lower therapy costs, benefiting patients and health insurers.
“Our partnership aims to overcome obstacles we face when acting alone,” said Jan Ewert, Managing Director of BIOTRONIK Australia and New Zealand. “We look forward to collaborating with GenesisCare to work towards a common goal: redefining how patients receive the best possible care.”
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
